Monday, October 24, 2011

Amgen's Third Quarter 2011 Revenue and Adjusted Earnings Per Share (EPS) Each Increased 3 Percent to $3.9 Billion and $1.40

2011 Total Revenue and Adjusted EPS Guidance Ranges Increased to $15.4-$15.6 Billion and $5.15-$5.30

Amgen’s Board of Directors Increased Stock Repurchase Authorization to $10 Billion

Third Quarter 2011 GAAP EPS Were $0.50 as a Result of a Legal Settlement Reserve

THOUSAND OAKS, Calif., Oct. 24, 2011 /PRNewswire via COMTEX/—Amgen (NASDAQ: AMGN) reported total revenue increased 3 percent during the third quarter of 2011 to $3,944 million versus $3,816 million in the third quarter of 2010. Total product sales increased 3 percent in the third quarter of 2011 to $3,877 million versus $3,759 million in the third quarter of 2010.

Read the rest of this entry

Posted in Press Releases

Wednesday, October 19, 2011

Amgen Announces Webcast of 2011 Third Quarter Financial Results

THOUSAND OAKS, Calif., Oct. 19, 2011 /PRNewswire via COMTEX/—Amgen (NASDAQ: AMGN) today announced that it will report its third quarter financial results on Monday, Oct. 24, 2011 after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m.  Pacific Time. Participating in the call from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen’s senior management team.

Read the rest of this entry

Posted in Press Releases

Wednesday, October 19, 2011

Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations

THOUSAND OAKS, Calif., Oct. 19, 2011 /PRNewswire via COMTEX/—Amgen (NASDAQ: AMGN) today announced the appointment of Anthony (Tony) Hooper, executive vice president, Global Commercial Operations, effective October 26th. In this role, Hooper will report to Robert A. Bradway, president and chief operating officer, and will be responsible for the Company’s Global Commercial Operations.

Read the rest of this entry

Posted in Press Releases

Thursday, October 13, 2011

Amgen Appoints Robert A. Bradway to the Company's Board of Directors

THOUSAND OAKS, Calif., Oct. 13, 2011 /PRNewswire via COMTEX/—Amgen (NASDAQ: AMGN) announced today that its Board of Directors has appointed Robert A. Bradway to the Company’s Board. Bradway, 48, is Amgen’s president and chief operating officer. The addition of Bradway brings the number of Amgen board members to 13.

Read the rest of this entry

Posted in Press Releases

Thursday, October 13, 2011

Amgen Announces 2011 Fourth Quarter Dividend

THOUSAND OAKS, Calif., Oct. 13, 2011 /PRNewswire via COMTEX/—Amgen (NASDAQ: AMGN) announced that its Board of Directors today declared a $0.28 per share dividend for the fourth quarter of 2011.  The dividend will be paid on Dec. 8, 2011 to all stockholders of record as of the close of business on Nov.  17, 2011.

Read the rest of this entry

Posted in Press Releases